Tuberculosis
Tuberculosis

Tuberculosis in South-East Asia Region

The WHO South-East Asia (SEA) Region, home to 26% of the world’s population with 43% burden of TB incidence (WHO Global TB Report 2021). It is estimated that in 2020, nearly 4.3 million people fell ill with TB and estimated 700 000 died (excluding HIV+TB mortality) because of the disease which is more than half of global TB deaths estimated at 1.3 million for the year. TB deaths showed an upward trend in more than a decade and are now very close to the levels seen in 2015. Treatment success for new and relapse TB cases was 85% (2019 cohort).

While WHO did not publish Rifampicin-resistant (RR) and multi-drug-resistant TB (MDR-TB) burden estimates in its 2021 Global TB Report, it is stated in the report that RR-/MDR-TB burden levels were at similar levels as previous year.  Therefore, it is assumed that the number of such cases were around 170 000 for 2021 as well, accounting for nearly 37% of global incidence. Of these, 64 970 were detected in 2020 (decline from 86 623 in 2019) and only 58 181 were enrolled on treatment (declining from 70 120) in the same year.

Six of global high TB burden countries are in the SEA Region: Bangladesh, Democratic People’s Republic of Korea, India, Indonesia, Myanmar and Thailand while for RR-/MDR-TB burden, Nepal replaces Thailand in the high-burden list for the Region.

Find out how COVID-19 related service disruption will impact TB epidemiology in the SEAR Member States

Technical links

-

587 million

out of 1.7 billion

infected by TB globally live in SEAR

SEA Region bears

nearly half

the global burden of TB disease



Our work

All →

Call for applications

News

Multimedia

Featured publications

All →
Sustain Accelerate Innovate - South-East Asia: flagship priority programmes driving impact in countries for the health of billions

WHO South-East Asia Region has been making rapid, inclusive and sustained progress on each of its eight flagship programmes. The publication compiles 11...

Regional strategic plan towards ending TB in the WHO South-East Asia Region: 2021–2025

The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs)....

Our Journey together. Our journey ahead: A more responsive WHO in the South-East Asia Region

Progress towards ending TB faced significant setbacks in 2020 due to the COVID-19 pandemic, which reduced TB notifications and disrupted treatment. Nevertheless,...

Optimizing active case-finding for tuberculosis

The WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic...

A situational analysis of programmatic management of TB preventive treatment in the WHO South-East Asia Region

Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The...

South-East Asia Regional Action Plan on Programmatic Management of Latent Tuberculosis 
Infection

Latent tuberculosis infection (LTBI) is a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of...

Meetings and Events

All →
National TB Programme Managers, 
partners and experts meeting to review 
progress on End TB milestones in 
South-East Asia Region

Summary recommendations of the meeting 1. Improving access to diagnostic and treatment services a. Plan and implement intensified case-finding activities...

Report of the first meeting of the Strategic and Technical Advisory Group for TB in the WHO South-East Asia Region

Tuberculosis (TB) is a major public health challenge in the South-East Asia (SEA) Region of WHO. Over 43% of the global TB incidence and half of the TB...

The Thirteenth Meeting of the South-East Asia Regional MDR-TB Advisory Committee (‎SEA RGLC)‎

The WHO South-East Asia Region (SEAR) accounts for an estimated 171 000 rifampicin-resistant tuberculosis (RR-TB) and multidrug-resistant tuberculosis...

Evaluation of implementation of regional flagship areas in the WHO South-East Asia Region 2014–2018

Regional Flagship Areas provided acceleration and thrust to the key health priorities of the SEA Region. WHO has made significant contributions towards...